Skip to content

Comparison Of Two Homeopathic Treatment Methods In Patients With Atopic Dermatitis

A Comparative Study Of J.T.Kent And Allens Keynote Approach In Atopic Dermatitis Based On Scoring Atopic Dermatitis Index - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/105088
Enrollment
30
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20- Atopic dermatitis

Interventions

Intervention1: Individualised Homeopathic Medicine: Participants diagnosed with Atopic Dermatitis will receive individualized homoeopathic treatment based on either the J. T. Kent repertorial approac

Sponsors

C D Pachchigar College Of Homeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 5-50 years 2 Both sexes. 3 Diagnosed based on clinical features. 4 To apply the SCOARD index to measure baseline severity and post treatment improvement.

Exclusion criteria

Exclusion criteria: 1 Severe atopic dermatitis requiring emergency care. 2 Major systemic illness(HIV,CANCER,TB,CRF)Patients with other chronic dermatological diseases ( e,g., skin cancer, psoriasis, vitiligo, lichen planus.)

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of prescriptions based on J. T. Kent s Homoeopathic Materia Medica and Allen s Keynote Materia Medica in the management of Atopic Dermatitis by assessing clinical presentation and evaluating severity and improvement using the SCORAD indexTimepoint: The total duration of the study will be 9 months, including case selection, intervention, follow-up, data collection, and statistical analysis.

Secondary

MeasureTime frame
The secondary outcome of the study will be to assess the reduction in individual symptoms of Atopic Dermatitis, evaluate improvement in the patient s quality of life, observe the frequency of relapses during the follow-up period, and measure the reduction in SCORAD score after treatment.Timepoint: The total duration of the study will be 9 months, including case selection, intervention, follow-up, data collection, and statistical analysis.

Countries

India

Contacts

Public ContactDr Gaurang Dave

C D Pachchigar College Of Homeopathic And Hospital

drgaurangdave@gmail.com8141699333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026